Brief: Usana Health Sciences Sees 2020 Diluted Eps $4.00 - $4.90

USANA Health Sciences

21/04/2020 22:55

April 21 (Reuters) - USANA Health Sciences Inc  USNA.N :
    * USANA HEALTH SCIENCES REPORTS FIRST QUARTER RESULTS
    * Q1 SALES $266.6 MILLION
    * UPDATED 2020 OUTLOOK REFLECTS IMPACT OF A STRONGER U.S.
DOLLAR
AND CONTINUED UNCERTAINTY SURROUNDING COVID-19
    * USANA HEALTH SCIENCES QTRLY DILUTED EPS $1.23
    * USANA HEALTH SCIENCES - MANUFACTURING FACILITIES IN U.S. &
CHINA
REMAIN FULLY OPERATIONAL TO DATE
    * USANA HEALTH SCIENCES - HAVE EXPERIENCED NO MEANINGFUL
DISRUPTIONS TO WORLD-WIDE SUPPLY CHAIN
    * SEES 2020 CONSOLIDATED NET SALES $1.00 - $1.08 BILLION
    * SEES 2020 DILUTED EPS $4.00 - $4.90
    * USANA HEALTH SCIENCES - HAS TEMPORARILY SUSPENDED SHARE
REPURCHASE PROGRAM

Source text for Eikon:  ID:nBw3PjWgDa 
Further company coverage:  USNA.N 

 ((Briefs@thomsonreuters.com;))